Litcius/Paper detail

Hemorrhagic and thrombotic adverse events associated with emicizumab and extended half-life factor VIII replacement drugs: EudraVigilance data of 2021

Maria Abbattista, Alessandro Ciavarella, Declan Noone, Flora Peyvandi

2023Journal of Thrombosis and Haemostasis41 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdverse effectInternal medicineOdds ratioAdverse drug reactionDrugGastroenterologyPharmacologyHemophilia Treatment and ResearchCoagulation, Bradykinin, Polyphosphates, and AngioedemaHeparin-Induced Thrombocytopenia and Thrombosis
Hemorrhagic and thrombotic adverse events associated with emicizumab and extended half-life factor VIII replacement drugs: EudraVigilance data of 2021 | Litcius